Navilyst Medical Inc. isn’t in the business of making headlines. Company management left the front pages behind when private equity firm Avista Capital Partners acquired the venous access and fluid management businesses from constant newsmaker Boston Scientific Corp. back in February. [See Deal] Since the spin out, Navilyst executives have melded the two businesses into a single company with designs on becoming "the first choice" for venous access and fluid management devices.
Unlike Boston Scientific, Navilyst won’t be swinging for the fences with high profile acquisitions of technology-heavy, high-growth businesses like Guidant...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?